Understanding how glucose transport varies in lung adenocarcinoma
Investigating the heterogeneity of glucose transport in lung adenocarcinoma
This study is looking at how a specific sugar transporter in your body affects lung cancer, especially in its early stages, to help us understand how the disease grows and find better ways to treat it.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Los Angeles NIH-funded |
| Lab location | 1 site (Los Angeles, United States) |
| Project ID | NIH-11013894 on NIH RePORTER |
What this research studies
This research investigates the role of glucose transport in lung adenocarcinoma, a common type of lung cancer. It focuses on the sodium-glucose transporter 2 (SGLT2) and its involvement in early-stage tumors, as well as how the expression of glucose transporters changes as the cancer progresses. By using advanced imaging techniques like positron emission tomography (PET), the study aims to explore the differences in glucose metabolism between early and advanced stages of the disease. This could lead to new insights into how lung cancer develops and progresses, potentially informing future treatment strategies.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with early-stage lung adenocarcinoma.
Not a fit: Patients with advanced lung cancer who do not express SGLT2 may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved understanding and treatment options for lung adenocarcinoma patients.
How similar studies have performed: Previous research has shown promising results in targeting glucose metabolism in cancer, suggesting potential for success in this approach.
Where this research is happening
Los Angeles, United States
- University of California Los Angeles — Los Angeles, United States (Active)
Researchers
- Principal investigator: Scafoglio, Claudio — University of California Los Angeles
- Study coordinator: Scafoglio, Claudio
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.